Gorilla Healing

Provider Profile Name: Gorilla Healing
Website: gorillahealing.com
Provider Type: Research/Wellness Peptide Vendor 

Operating Details

• E-commerce product sales
• No insurance, no HSA/FSA
• Products sold without requiring prescriptions from licensed practitioners
• Customers reconstitute products themselves with bacteriostatic water
• No medical director, no clinical team, no licensed pharmacy relationship
• FDA warning letter received October 2, 2023 

What Gorilla Healing Sells

Gorilla Healing operates as a wellness and peptide product e-commerce site. Reviews describe customers ordering products, receiving them, and reconstituting them with bacteriostatic water themselves — a process that requires knowledge of sterile reconstitution technique and introduces meaningful risk of contamination, improper dosing, and injection error. No clinical intake, no provider review, and no prescription verification are part of the transaction.

Reviewer accounts mention purchasing semaglutide and self-administering without any medical supervision, clinical intake form, or licensed provider review. The site also sells a broad range of other peptide and wellness products including nasal sprays and other injectable compounds.

FDA Warning Letter — October 2, 2023

The FDA reviewed Gorilla Healing’s website and found it was offering unapproved and misbranded semaglutide and tirzepatide products for sale, causing their introduction into interstate commerce in violation of the Federal Food, Drug, and Cosmetic Act.

Specific violations cited by the FDA:

GLP-1 Weight Loss

• Lose pounds of fat every week
• Money Back Guarantee
• No membership or hidden fees! Everything you need is included
• Start for just $179, no insurance required + free shipping

GLP-1 for Just $179

100k MembersHSA/FSA ApprovedFrom $179

The semaglutide and tirzepatide products offered on gorillahealing.com had no approved drug applications in effect — meaning they were not FDA-approved finished drugs, not compounded medications dispensed pursuant to a prescription from a licensed healthcare practitioner, and not products that had been evaluated for safety, effectiveness, or quality by the FDA.

Furthermore, the FDA noted that Gorilla Healing did not provide information or instructions on how to prepare or dose the products — a fact the agency stated heightened the public health concern and may further contribute to the potential for patient harm.

The FDA also stated that Gorilla Healing was selling semaglutide and tirzepatide without ensuring customers had prescriptions from licensed healthcare practitioners — a fundamental violation of federal prescription drug law.

After being contacted by Reuters following the warning letter’s publication, Gorilla Healing stated it had not seen the FDA’s letter. At the time of reporting, the site was still listing semaglutide 5mg and tirzepatide 10mg for sale.

Pricing and Reviews

Gorilla Healing has 75 Trustpilot reviews. Review content reflects the e-commerce peptide vendor model: customers comment on shipping speed, packaging, and product effectiveness from self-directed use — not on clinical consultations, provider interactions, or treatment plans. Some reviewers report fast shipping and positive results; others describe non-shipment and inability to get a response from the vendor.

No pricing details are independently verifiable for current GLP-1 product offerings.

Compounding Pharmacies Used

Gorilla Healing does not use a licensed compounding pharmacy.

Products are shipped directly from the vendor with no pharmacy licensure, no 503A or 503B designation, no Certificate of Analysis disclosed publicly, and no pharmacist in the supply chain.

Note: Gorilla Healing received an FDA warning letter in October 2023 for selling unapproved and misbranded semaglutide and tirzepatide without requiring prescriptions, and without providing dosing or preparation instructions. It is not a licensed telehealth provider, does not employ clinicians, and does not operate within the prescription drug or compounding pharmacy regulatory framework. It is included here solely because it appears in the source directory. BariatricReports.org readers seeking GLP-1 treatment for weight management should use only licensed telehealth platforms that require a valid prescription from a state-licensed medical professional and dispense through a licensed compounding pharmacy. Purchasing GLP-1-class compounds from unregulated vendors carries serious safety risks including unknown purity, potency, and sterility, with no clinical oversight of dosing or contraindication screening.